Microangiopathic hemolytic anemia with metastatic adenocarcinoma: response to chemotherapy.
Microangiopathic hemolytic anemia developed in two patients with metastatic malignancy, one with primary carcinoma of the colon and the other with ovarian carcinoma. There was no evidence of consumptive coagulopathy except severe thrombocytolysis in one patient. Both patients improved remarkably after chemotherapy. The colonic carcinoma responded to 5-fluorouracil delivered into the hepatic artery, and the ovarian tumor to multiagent systemic therapy.
D000230:Adenocarcinoma / Q000097:blood* / Q000473:pathology / Q000556:secondary; D000368:Aged; D000743:Anemia, Hemolytic / Q000209:etiology*; D003110:Colonic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000556:secondary